Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy

Por Wilke, Russell A., Berg, Richard L., Vidaillet, Humberto J., Caldwell, Michael D., Burmester, James K., Hillman, Michael A.
Publicado em 2005

A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data

Por Hillman, Michael A., Wilke, Russell A., Yale, Steven H., Vidaillet, Humberto J., Caldwell, Michael D., Glurich, Ingrid, Berg, Richard L., Schmelzer, John, Burmester, James K.
Publicado em 2005